Leavell Investment Management’s Biogen BIIB Stock Holding History

Leavell Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-800	Closed	-$224K	–	396
2021 Q2	$224K	Hold	800	–	–	0.02%	373
2021 Q1	$224K	Buy	+800	New	+$216K	0.02%	373
2020 Q4	–	Sell	-800	Closed	-$227K	–	375
2020 Q3	$227K	Hold	800	–	–	0.02%	346
2020 Q2	$214K	Hold	800	–	–	0.02%	347
2020 Q1	$253K	Hold	800	–	–	0.03%	308
2019 Q4	$237K	Sell	800 -400	-33%	-$111K	0.02%	356
2019 Q3	$279K	Sell	1,200 -200	-14%	-$46.6K	0.03%	328
2019 Q2	$327K	Buy	1,400 +500	+56%	+$115K	0.03%	306
2019 Q1	$213K	Hold	900	–	–	0.02%	359
2018 Q4	$271K	Buy	+900	New	+$287K	0.03%	320
2017 Q2	–	Sell	-890	Closed	-$243K	–	368
2017 Q1	$243K	Hold	890	–	–	0.03%	335
2016 Q4	$252K	Buy	+890	New	+$264K	0.03%	331

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Leavell Investment Management's BIIB Position: Q3 2021 in Review

Leavell Investment Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 800 shares — an estimated $224K sold.

Leavell Investment Management first reported a position in BIIB in Q4 2016 and held it in 12 quarters. The position peaked at $327K in Q2 2019. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

Leavell Investment Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
Leavell Investment Management sold 800 Biogen shares in Q3 2021, an estimated $224K.
Leavell Investment Management first reported a position in Biogen in Q4 2016 and held it in 12 quarters.
Leavell Investment Management's Biogen position peaked at $327K in Q2 2019.
1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Leavell Investment Management's 13F filing for Q3 2021, filed 26 Oct 2021.